PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 19 filers reported holding PLX PHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | -88.9% | 394 | -69.7% | 0.00% | – |
| Q2 2019 | $9,000 | +50.0% | 1,300 | +8.3% | 0.00% | – |
| Q1 2019 | $6,000 | -82.4% | 1,200 | -85.7% | 0.00% | – |
| Q3 2018 | $34,000 | – | 8,412 | +420500.0% | 0.00% | – |
| Q2 2018 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 62,673 | $385,000 | 1.14% |
| Park West Asset Management LLC | 1,075,723 | $6,616,000 | 0.37% |
| 683 Capital Management, LLC | 290,909 | $1,789,000 | 0.26% |
| Heritage Way Advisors, LLC | 32,101 | $197,000 | 0.17% |
| Tower Research Capital LLC (TRC) | 751 | $5,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 229,800 | $1,413,000 | 0.00% |
| UBS Group AG | 53 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,302 | $8,000 | 0.00% |
| DEUTSCHE BANK AG\ | 2 | $0 | 0.00% |
| GOLDMAN SACHS GROUP INC | 11,450 | $70,000 | 0.00% |